

Author: Dézsi Livia Vécsei László
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.23, Iss.5, 2014-05, pp. : 729-742
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content


Safinamide in the treatment of Parkinson's disease
Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. :


Safinamide an appealing adjunct in Parkinson's disease
Inpharma, Vol. 1, Iss. 1588, 2007-01 ,pp. :


Istradefylline for the treatment of Parkinson's disease
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. :


Apomorphine in the treatment of Parkinson's disease
Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. :